Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: QUAORIPLEJIA; This spontaneous report was received from a regulatory authority refers to a female patient on unknown age. There was no information about the patient''s concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient started therapy with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (manufacturer unknown) dose 4 (route of administration, strength, frequency, lot #, expiration date and indication were not reported). On an unknown date, the patient experienced quadriplegia. The outcome of the event was reported as fatal. It was not reported if autopsy was performed. The Agency considered the event of quadriplegia to be non-serious. Upon internal review the report was upgraded to priority 2 due to the outcome of the event. The causality assessment between the event and suspect therapy was not reported.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166